4[1]Chen CJ,Yu MW,Liaw YF.Epidemiological characteristics and risk factors of hepatocellular carcinoma.J Gastroenterol Hepatol 1997; 12:S294-S308
5[2]Oshima M,Murai N,Kargman S,Arguello M,Luk P,Kwong E,Taketo MM,Evans JF.Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib,a specific cyclooxygenase-2 inhibitor.Cancer Res 2001; 61:1733-1740
6[3]Hussain T,Gupta S,Mukhtar H.Cyclooxygenase-2 and prostate carcinogenesis.Cancer Left 2003; 191:125-135
7[4]Peng JP,Su CY,Chang HC,Chai CY,Hung WC.Overexpression of cyclo-oxygenase 2 in squamous cell carcinoma of the hypopharynx.Hum Pathol 2002; 33:100-104
8[5]Sung YK,Hwang SY,Kim JO,Bae HI,Kim JC,Kim MK.The correlation between cyclooxygenase-2 expression and hepatocellular carcinogenesis.Mol Cells 2004; 17:35-38
